These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30690794)

  • 1. Observations on the Natural History of Camurati-Engelmann Disease.
    Hughes P; Hassan I; Que L; Mead P; Lee JH; Love DR; Prosser DO; Cundy T
    J Bone Miner Res; 2019 May; 34(5):875-882. PubMed ID: 30690794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marked phenotypic variability in progressive diaphyseal dysplasia (Camurati-Engelmann disease): report of a four-generation pedigree, identification of a mutation in TGFB1, and review.
    Wallace SE; Lachman RS; Mekikian PB; Bui KK; Wilcox WR
    Am J Med Genet A; 2004 Sep; 129A(3):235-47. PubMed ID: 15326622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orthopedic Manifestations of Type I Camurati-Engelmann Disease.
    Yuldashev AJ; Shin CH; Kim YS; Jang WY; Park MS; Chae JH; Yoo WJ; Choi IH; Kim OH; Cho TJ
    Clin Orthop Surg; 2017 Mar; 9(1):109-115. PubMed ID: 28261436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The first Korean case of Camurati-Engelmann disease (progressive diaphyseal dysplasia) confirmed by TGFB1 gene mutation analysis.
    Park SJ; Yoon CS; Park HW; Choi JR; Chung JS; Lee KA
    J Korean Med Sci; 2009 Aug; 24(4):737-40. PubMed ID: 19654961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An ENU-induced p.C225S missense mutation in the mouse Tgfb1 gene does not cause Camurati-Engelmann disease-like skeletal phenotypes.
    Ichimura S; Sasaki S; Murata T; Fukumura R; Gondo Y; Ikegawa S; Furuichi T
    Exp Anim; 2017 May; 66(2):137-144. PubMed ID: 27928112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Camurati-Engelmann disease type II: progressive diaphyseal dysplasia with striations of the bones.
    Nishimura G; Nishimura H; Tanaka Y; Makita Y; Ikegawa S; Ghadami M; Kinoshita A; Niikawa N
    Am J Med Genet; 2002 Jan; 107(1):5-11. PubMed ID: 11807860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and identification of a novel TGFB1 variant in three unrelated Chinese families with Camurati-Engelmann disease.
    Tao XH; Yang XG; Wang ZY; Xu Y; Lin XY; Xu T; Zhang ZL; Yue H
    Mol Genet Genomic Med; 2022 May; 10(5):e1922. PubMed ID: 35315241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mutation of TGF beta1 in a Chinese family with Camurati-Engelmann disease.
    Wu S; Liang S; Yan Y; Wang Y; Li F; Deng Y; Huang W; Yuan W; Luo N; Zhu C; Wang Y; Li Y; Liu M; Wu X
    Bone; 2007 Jun; 40(6):1630-4. PubMed ID: 17433803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Camurati-Engelmann disease: unique variant featuring a novel mutation in TGFβ1 encoding transforming growth factor beta 1 and a missense change in TNFSF11 encoding RANK ligand.
    Whyte MP; Totty WG; Novack DV; Zhang X; Wenkert D; Mumm S
    J Bone Miner Res; 2011 May; 26(5):920-33. PubMed ID: 21541994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Camurati-Engelmann disease (progressive diaphyseal dysplasia) in a Moroccan family.
    Simsek S; Janssens K; Kwee ML; Van Hul W; Veenstra J; Netelenbos JC
    Osteoporos Int; 2005 Sep; 16(9):1167-70. PubMed ID: 15959620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Camurati-Engelmann disease--a rare cause of bone pain.
    Mundra V; Taxel P
    Conn Med; 2012 Jan; 76(1):33-7. PubMed ID: 22372177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Camurati-Engelmann Disease.
    Van Hul W; Boudin E; Vanhoenacker FM; Mortier G
    Calcif Tissue Int; 2019 May; 104(5):554-560. PubMed ID: 30721323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Camurati-Engelmann disease with obesity in a newly identified family carrying a missense p.Arg156Cys mutation in the TGFB1 gene.
    Collet C; Laplanche JL; de Vernejoul MC
    Am J Med Genet A; 2013 Aug; 161A(8):2074-7. PubMed ID: 23824952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Camurati-Engelmann disease: contribution of bone scintigraphy to genetic counseling.
    Clybouw C; Desmyttere S; Bonduelle M; Piepsz A
    Genet Couns; 1994; 5(2):195-8. PubMed ID: 7917133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and treatment outcomes in Camurati-Engelmann disease: A case series.
    Kim YM; Kang E; Choi JH; Kim GH; Yoo HW; Lee BH
    Medicine (Baltimore); 2018 Apr; 97(14):e0309. PubMed ID: 29620655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-β1 gene mutations and phenotypes in pediatric patients with Camurati‑Engelmann disease.
    Wang C; Zhang BH; Liu YJ; Hu YQ; He JW; Zhang ZL
    Mol Med Rep; 2013 May; 7(5):1695-9. PubMed ID: 23503840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A family with Camurati-Engelman disease. The role of the missense p.R218C mutation in TGFB1 in bones and endocrine glands.
    Toumba M; Neocleous V; Shammas C; Anastasiadou V; Allgrove J; Phylactou LA; Skordis N
    J Pediatr Endocrinol Metab; 2013; 26(9-10):987-93. PubMed ID: 23729546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic variability at the TGF-beta1 locus in Camurati-Engelmann disease.
    Campos-Xavier B; Saraiva JM; Savarirayan R; Verloes A; Feingold J; Faivre L; Munnich A; Le Merrer M; Cormier-Daire V
    Hum Genet; 2001 Dec; 109(6):653-8. PubMed ID: 11810278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mutation affecting the latency-associated peptide of TGFbeta1 in Camurati-Engelmann disease enhances osteoclast formation in vitro.
    McGowan NW; MacPherson H; Janssens K; Van Hul W; Frith JC; Fraser WD; Ralston SH; Helfrich MH
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3321-6. PubMed ID: 12843182
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.